Use of GP IIb, IIIa inhibitors in coronary syndromes: state of the art ; proceedings of an international roundtable held in Davos, Switzerland, 15 - 16 February 1997
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
London [u.a.]
Saunders
1998
|
| Schriftenreihe: | [European heart journal / Supplement]
19D |
| Schlagworte: | |
| Beschreibung: | 66 S. Ill., graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV011900672 | ||
| 003 | DE-604 | ||
| 005 | 19990507 | ||
| 007 | t | ||
| 008 | 980422s1998 ad|| |||| 10||| eng d | ||
| 035 | |a (OCoLC)47313229 | ||
| 035 | |a (DE-599)BVBBV011900672 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 |a DE-29 |a DE-355 |a DE-12 | ||
| 084 | |a YB 9505 |0 (DE-625)153178:12911 |2 rvk | ||
| 245 | 1 | 0 | |a Use of GP IIb, IIIa inhibitors in coronary syndromes |b state of the art ; proceedings of an international roundtable held in Davos, Switzerland, 15 - 16 February 1997 |c ed. by R. M. Califf ... |
| 264 | 1 | |a London [u.a.] |b Saunders |c 1998 | |
| 300 | |a 66 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a [European heart journal / Supplement] |v 19D | |
| 650 | 0 | 7 | |a Inhibitor |0 (DE-588)4027007-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Glykoproteine |0 (DE-588)4071905-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Antigen CD41 |0 (DE-588)4604678-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Koronare Herzkrankheit |0 (DE-588)4073731-7 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1997 |z Davos |2 gnd-content | |
| 689 | 0 | 0 | |a Koronare Herzkrankheit |0 (DE-588)4073731-7 |D s |
| 689 | 0 | 1 | |a Glykoproteine |0 (DE-588)4071905-4 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Koronare Herzkrankheit |0 (DE-588)4073731-7 |D s |
| 689 | 1 | 1 | |a Antigen CD41 |0 (DE-588)4604678-1 |D s |
| 689 | 1 | 2 | |a Inhibitor |0 (DE-588)4027007-5 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Califf, Robert M. |e Sonstige |4 oth | |
| 810 | 2 | |a Supplement] |t [European heart journal |v 19D |w (DE-604)BV000900709 |9 19D | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-008041968 | ||
Datensatz im Suchindex
| _version_ | 1804126487577624576 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV011900672 |
| classification_rvk | YB 9505 |
| ctrlnum | (OCoLC)47313229 (DE-599)BVBBV011900672 |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01677nam a2200421 cb4500</leader><controlfield tag="001">BV011900672</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19990507 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">980422s1998 ad|| |||| 10||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)47313229</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV011900672</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-12</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YB 9505</subfield><subfield code="0">(DE-625)153178:12911</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Use of GP IIb, IIIa inhibitors in coronary syndromes</subfield><subfield code="b">state of the art ; proceedings of an international roundtable held in Davos, Switzerland, 15 - 16 February 1997</subfield><subfield code="c">ed. by R. M. Califf ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London [u.a.]</subfield><subfield code="b">Saunders</subfield><subfield code="c">1998</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">66 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">[European heart journal / Supplement]</subfield><subfield code="v">19D</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Inhibitor</subfield><subfield code="0">(DE-588)4027007-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Glykoproteine</subfield><subfield code="0">(DE-588)4071905-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Antigen CD41</subfield><subfield code="0">(DE-588)4604678-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Koronare Herzkrankheit</subfield><subfield code="0">(DE-588)4073731-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1997</subfield><subfield code="z">Davos</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Koronare Herzkrankheit</subfield><subfield code="0">(DE-588)4073731-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Glykoproteine</subfield><subfield code="0">(DE-588)4071905-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Koronare Herzkrankheit</subfield><subfield code="0">(DE-588)4073731-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Antigen CD41</subfield><subfield code="0">(DE-588)4604678-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Inhibitor</subfield><subfield code="0">(DE-588)4027007-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Califf, Robert M.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="810" ind1="2" ind2=" "><subfield code="a">Supplement]</subfield><subfield code="t">[European heart journal</subfield><subfield code="v">19D</subfield><subfield code="w">(DE-604)BV000900709</subfield><subfield code="9">19D</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-008041968</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1997 Davos gnd-content |
| genre_facet | Konferenzschrift 1997 Davos |
| id | DE-604.BV011900672 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T18:18:14Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-008041968 |
| oclc_num | 47313229 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM DE-29 DE-355 DE-BY-UBR DE-12 |
| owner_facet | DE-19 DE-BY-UBM DE-29 DE-355 DE-BY-UBR DE-12 |
| physical | 66 S. Ill., graph. Darst. |
| publishDate | 1998 |
| publishDateSearch | 1998 |
| publishDateSort | 1998 |
| publisher | Saunders |
| record_format | marc |
| series2 | [European heart journal / Supplement] |
| spelling | Use of GP IIb, IIIa inhibitors in coronary syndromes state of the art ; proceedings of an international roundtable held in Davos, Switzerland, 15 - 16 February 1997 ed. by R. M. Califf ... London [u.a.] Saunders 1998 66 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier [European heart journal / Supplement] 19D Inhibitor (DE-588)4027007-5 gnd rswk-swf Glykoproteine (DE-588)4071905-4 gnd rswk-swf Antigen CD41 (DE-588)4604678-1 gnd rswk-swf Koronare Herzkrankheit (DE-588)4073731-7 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1997 Davos gnd-content Koronare Herzkrankheit (DE-588)4073731-7 s Glykoproteine (DE-588)4071905-4 s DE-604 Antigen CD41 (DE-588)4604678-1 s Inhibitor (DE-588)4027007-5 s Califf, Robert M. Sonstige oth Supplement] [European heart journal 19D (DE-604)BV000900709 19D |
| spellingShingle | Use of GP IIb, IIIa inhibitors in coronary syndromes state of the art ; proceedings of an international roundtable held in Davos, Switzerland, 15 - 16 February 1997 Inhibitor (DE-588)4027007-5 gnd Glykoproteine (DE-588)4071905-4 gnd Antigen CD41 (DE-588)4604678-1 gnd Koronare Herzkrankheit (DE-588)4073731-7 gnd |
| subject_GND | (DE-588)4027007-5 (DE-588)4071905-4 (DE-588)4604678-1 (DE-588)4073731-7 (DE-588)1071861417 |
| title | Use of GP IIb, IIIa inhibitors in coronary syndromes state of the art ; proceedings of an international roundtable held in Davos, Switzerland, 15 - 16 February 1997 |
| title_auth | Use of GP IIb, IIIa inhibitors in coronary syndromes state of the art ; proceedings of an international roundtable held in Davos, Switzerland, 15 - 16 February 1997 |
| title_exact_search | Use of GP IIb, IIIa inhibitors in coronary syndromes state of the art ; proceedings of an international roundtable held in Davos, Switzerland, 15 - 16 February 1997 |
| title_full | Use of GP IIb, IIIa inhibitors in coronary syndromes state of the art ; proceedings of an international roundtable held in Davos, Switzerland, 15 - 16 February 1997 ed. by R. M. Califf ... |
| title_fullStr | Use of GP IIb, IIIa inhibitors in coronary syndromes state of the art ; proceedings of an international roundtable held in Davos, Switzerland, 15 - 16 February 1997 ed. by R. M. Califf ... |
| title_full_unstemmed | Use of GP IIb, IIIa inhibitors in coronary syndromes state of the art ; proceedings of an international roundtable held in Davos, Switzerland, 15 - 16 February 1997 ed. by R. M. Califf ... |
| title_short | Use of GP IIb, IIIa inhibitors in coronary syndromes |
| title_sort | use of gp iib iiia inhibitors in coronary syndromes state of the art proceedings of an international roundtable held in davos switzerland 15 16 february 1997 |
| title_sub | state of the art ; proceedings of an international roundtable held in Davos, Switzerland, 15 - 16 February 1997 |
| topic | Inhibitor (DE-588)4027007-5 gnd Glykoproteine (DE-588)4071905-4 gnd Antigen CD41 (DE-588)4604678-1 gnd Koronare Herzkrankheit (DE-588)4073731-7 gnd |
| topic_facet | Inhibitor Glykoproteine Antigen CD41 Koronare Herzkrankheit Konferenzschrift 1997 Davos |
| volume_link | (DE-604)BV000900709 |
| work_keys_str_mv | AT califfrobertm useofgpiibiiiainhibitorsincoronarysyndromesstateoftheartproceedingsofaninternationalroundtableheldindavosswitzerland1516february1997 |